Association of Tear Cytokine Concentrations with Symptoms and Signs of Dry Eye Disease: Baseline Data from the Dry Eye Assessment and Management (DREAM) Study

References

• Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, Liu Z, Nelson JD, Nichols JJ, Tsubota K, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15(3):276–283. doi:10.1016/j.jtos.2017.05.008.
   PubMed Web of Science ®Google Scholar
• Farrand KF, Fridman M, Stillman IO, Schaumberg DA. Prevalence of diagnosed dry eye disease in the united states among adults aged 18 years and older. Am J Ophthalmol. 2017;182:90–98. doi:10.1016/j.ajo.2017.06.033.
   PubMed Web of Science ®Google Scholar
• Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F, Na KS, Schaumberg D, Uchino M, Vehof J, et al. TFOS DEWS II epidemiology report. Ocul Surf. 2017;15(3):334–365. doi:10.1016/j.jtos.2017.05.003.
   PubMed Web of Science ®Google Scholar
• Wolffsohn JS, Arita R, Chalmers R, Djalilian A, Dogru M, Dumbleton K, Gupta PK, Karpecki P, Lazreg S, Pult H, et al. TFOS DEWS II diagnostic methodology report. Ocul Surf. 2017;15(3):539–574. doi:10.1016/j.jtos.2017.05.001.
   PubMed Web of Science ®Google Scholar
• Zeev MS, Miller DD, Latkany R. Diagnosis of dry eye disease and emerging technologies. Clin Ophthalmol. 2014;8:581–590. doi:10.2147/OPTH.S45444.
   PubMedGoogle Scholar
• Bartlett JD, Keith MS, Sudharshan L, Snedecor SJ. Associations between signs and symptoms of dry eye disease: a systematic review. Clin Ophthalmol. 2015;9:1719–1730. doi:10.2147/OPTH.S89700.
   PubMed Web of Science ®Google Scholar
• Sullivan BD, Crews LA, Messmer EM, Foulks GN, Nichols KK, Baenninger P, Geerling G, Figueiredo F, Lemp MA. Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications. Acta Ophthalmol. 2014;92(2):161–166. doi:10.1111/aos.12012.
   PubMed Web of Science ®Google Scholar
• Vehof J, Sillevis Smitt-Kamminga N, Nibourg SA, Hammond CJ. Predictors of discordance between symptoms and signs in dry eye disease. Ophthalmology. 2017;124(3):280–286. doi:10.1016/j.ophtha.2016.11.008.
   PubMed Web of Science ®Google Scholar
• Stern ME, Schaumburg CS, Pflugfelder SC. Dry eye as a mucosal autoimmune disease. Int Rev Immunol. 2013;32(1):19–41. doi:10.3109/08830185.2012.748052.
   PubMed Web of Science ®Google Scholar
• Stevenson W, Chauhan SK, Dana R. Dry eye disease: an immune-mediated ocular surface disorder. Arch Ophthalmol. 2012;130(1):90–100. doi:10.1001/archophthalmol.2011.364.
   PubMedGoogle Scholar
• Wei Y, Asbell PA. The core mechanism of dry eye disease is inflammation. Eye Contact Lens. 2014;40(4):248–256. doi:10.1097/ICL.0000000000000042.
   PubMed Web of Science ®Google Scholar
• Boehm N, Riechardt AI, Wiegand M, Pfeiffer N, Grus FH. Proinflammatory cytokine profiling of tears from dry eye patients by means of antibody microarrays. Invest Ophthalmol Vis Sci. 2011;52(10):7725–7730. doi:10.1167/iovs.11-7266.
   PubMed Web of Science ®Google Scholar
• Chen Y, Chauhan SK, Lee HS, Saban DR, Dana R. Chronic dry eye disease is principally mediated by effector memory Th17 cells. Mucosal Immunol. 2014;7(1):38–45. doi:10.1038/mi.2013.20.
   PubMed Web of Science ®Google Scholar
• Chen Y, Chauhan SK, Shao C, Omoto M, Inomata T, Dana R. IFN-gamma-Expressing Th17 Cells Are Required for Development of Severe Ocular Surface Autoimmunity. J Immunol. 2017;199(3):1163–1169. doi:10.4049/jimmunol.1602144.
   PubMed Web of Science ®Google Scholar
• de Paiva CS, Pflugfelder SC. Rationale for anti-inflammatory therapy in dry eye syndrome. Arq Bras Oftalmol. 2008;71(6 Suppl):89–95. doi:10.1590/s0004-27492008000700017.
   PubMed Web of Science ®Google Scholar
• Massingale ML, Li X, Vallabhajosyula M, Chen D, Wei Y, Asbell PA. Analysis of inflammatory cytokines in the tears of dry eye patients. Cornea. 2009;28(9):1023–1027. doi:10.1097/ICO.0b013e3181a16578.
   PubMed Web of Science ®Google Scholar
• Reyes JL, Vannan DT, Eksteen B, Avelar IJ, Rodríguez T, González MI, Mendoza AV. Innate and Adaptive Cell Populations Driving Inflammation in Dry Eye Disease. Mediators Inflamm. 2018;2018:1–12. doi:10.1155/2018/2532314.
   Web of Science ®Google Scholar
• Qi HCY, Inomata T, Amouzegar A, Dana R. IL-10-Producing Th17 Cells: a potentially regulatory cell population in dry eye disease. J Immunol and Immunother. 2018;2:1–7.
   Google Scholar
• Chen W, Cao H, Lin J, Olsen N, Zheng SG. Biomarkers for primary sjogren’s syndrome. Genomics Proteomics Bioinformatics. 2015;13(4):219–223. doi:10.1016/j.gpb.2015.06.002.
   PubMed Web of Science ®Google Scholar
• Hagan S. Biomarkers of ocular surface disease using impression cytology. Biomark Med. 2017;11(12):1135–1147. doi:10.2217/bmm-2017-0124.
   PubMed Web of Science ®Google Scholar
• Hagan S, Martin E, Enriquez-de-Salamanca A. Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine. Epma J. 2016;7(1):15. doi:10.1186/s13167-016-0065-3.
   PubMed Web of Science ®Google Scholar
• Roy NS, Wei Y, Kuklinski E, Asbell PA. The growing need for validated biomarkers and endpoints for dry eye clinical research. Invest Ophthalmol Vis Sci. 2017;58(6):BIO1–BIO19. doi:10.1167/iovs.17-21709.
   PubMed Web of Science ®Google Scholar
• Tamhane M, Cabrera-Ghayouri S, Abelian G, Viswanath V. Review of Biomarkers in Ocular Matrices: challenges and Opportunities. Pharm Res. 2019;36(3):40. doi:10.1007/s11095-019-2569-8.
   PubMed Web of Science ®Google Scholar
• Abdulkhaleq LA, Assi MA, Abdullah R, Zamri-Saad M, Taufiq-Yap YH, Hezmee MNM. The crucial roles of inflammatory mediators in inflammation: a review. Vet World. 2018;11(5):627–635. doi:10.14202/vetworld.2018.627-635.
   PubMed Web of Science ®Google Scholar
• Pflugfelder SC, Stern ME, Symposium P, Symposium Participants. Immunoregulation on the ocular surface: 2nd Cullen Symposium. Ocul Surf. 2009;7(2):67–77. doi:10.1016/S1542-0124(12)70297-5.
   PubMed Web of Science ®Google Scholar
• Turner MD, Nedjai B, Hurst T, Pennington DJ. Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease. Biochim Biophys Acta. 2014;1843(11):2563–2582. doi:10.1016/j.bbamcr.2014.05.014.
   PubMed Web of Science ®Google Scholar
• Jones DT, Monroy D, Pflugfelder SC. A novel method of tear collection: comparison of glass capillary micropipettes with porous polyester rods. Cornea. 1997;16(4):450–458.
   PubMed Web of Science ®Google Scholar
• Lam SM, Tong L, Duan X, Petznick A, Wenk MR, Shui G. Extensive characterization of human tear fluid collected using different techniques unravels the presence of novel lipid amphiphiles. J Lipid Res. 2014;55(2):289–298. doi:10.1194/jlr.M044826.
   PubMed Web of Science ®Google Scholar
• Djoba Siawaya JF, Roberts T, Babb C, Black G, Golakai HJ, Stanley K, Bapela NB, Hoal E, Parida S, Helden P, et al. An evaluation of commercial fluorescent bead-based luminex cytokine assays. PloS One. 2008;3(7):e2535. doi:10.1371/journal.pone.0002535.
   PubMed Web of Science ®Google Scholar
• Hagan S, Tomlinson A. Tear fluid biomarker profiling: a review of multiplex bead analysis. Ocul Surf. 2013;11(4):219–235. doi:10.1016/j.jtos.2013.04.004.
   PubMed Web of Science ®Google Scholar
• Wei Y, Gadaria-Rathod N, Epstein S, Asbell P. Tear cytokine profile as a noninvasive biomarker of inflammation for ocular surface diseases: standard operating procedures. Invest Ophthalmol Vis Sci. 2013;54(13):8327–8336. doi:10.1167/iovs.13-12132.
   PubMed Web of Science ®Google Scholar
• Le Guezennec X, Quah J, Tong L, Kim N. Human tear analysis with miniaturized multiplex cytokine assay on "wall-less" 96-well plate. Mol Vis. 2015;21:1151–1161.
   PubMed Web of Science ®Google Scholar
• Huang JF, Zhang Y, Rittenhouse KD, Pickering EH, McDowell MT. Evaluations of tear protein markers in dry eye disease: repeatability of measurement and correlation with disease. Invest Ophthalmol Vis Sci. 2012;53(8):4556–4564. doi:10.1167/iovs.11-9054.
   PubMed Web of Science ®Google Scholar
• Pinto-Fraga J, Enriquez-de-Salamanca A, Calonge M, González-García MJ, López-Miguel A, Rosa AL, García-Vázquez C, Calder V, Stern ME, Fernández I. Severity, therapeutic, and activity tear biomarkers in dry eye disease: an analysis from a phase III clinical trial. Ocul Surf. 2018;16(3):368–376. doi:10.1016/j.jtos.2018.05.001.
   PubMed Web of Science ®Google Scholar
• McDonnell PJ, Pflugfelder SC, Stern ME, Hardten DR, Taryn Conway TC, Villanueva L, Hollander DA. Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye. BMC Ophthalmol. 2017;17(1):265. doi:10.1186/s12886-017-0646-5.
   PubMed Web of Science ®Google Scholar
• Jackson DC, Zeng W, Wong CY, Mifsud EJ, Williamson NA, Ang CS, Vingrys AJ, Downie LE. Tear interferon-gamma as a biomarker for evaporative dry eye disease. Invest Ophthalmol Vis Sci. 2016;57(11):4824–4830. doi:10.1167/iovs.16-19757.
   PubMed Web of Science ®Google Scholar
• Lee SY, Han SJ, Nam SM, Yoon SC, Ahn JM, Kim TI, Kim EK, Seo KY. Analysis of tear cytokines and clinical correlations in Sjogren syndrome dry eye patients and non-Sjogren syndrome dry eye patients. Am J Ophthalmol. 2013;156(2):247–253 e241. doi:10.1016/j.ajo.2013.04.003.
   PubMed Web of Science ®Google Scholar
• Liu R, Gao C, Chen H, Li Y, Jin Y, Qi H. Analysis of Th17-associated cytokines and clinical correlations in patients with dry eye disease. PloS One. 2017;12(4):e0173301. doi:10.1371/journal.pone.0173301.
   PubMed Web of Science ®Google Scholar
• Mrugacz M, Ostrowska L, Bryl A, Szulc A, Zelazowska-Rutkowska B, Mrugacz G. Pro-inflammatory cytokines associated with clinical severity of dry eye disease of patients with depression. Adv Med Sci. 2017;62(2):338–344. doi:10.1016/j.advms.2017.03.003.
   PubMed Web of Science ®Google Scholar
• Roda M, Corazza I, Bacchi Reggiani ML, Pellegrini M, Taroni L, Giannaccare G, Versura P. Dry eye disease and tear cytokine levels-a meta-analysis. Int J Mol Sci. 2020;21(9):3111.
   PubMed Web of Science ®Google Scholar
• Asbell PA, Maguire MG, Pistilli M, Ying GS, Szczotka-Flynn LB, Hardten DR, Lin MC, Shtein RM, Dry Eye Assessment and Management Study Research Group. n-3 fatty acid supplementation for the treatment of dry eye disease. N Engl J Med. 2018;378(18):1681–1690. doi:10.1056/NEJMoa1709691.
   PubMed Web of Science ®Google Scholar
• Asbell PA, Maguire MG, Peskin E, Bunya VY, Kuklinski EJ, Dry Eye Assessment and Management (DREAM©) Study Research Group. Dry Eye Assessment and Management (DREAM(c)) Study: study design and baseline characteristics. Contemp Clin Trials. 2018;71:70–79. doi:10.1016/j.cct.2018.06.002.
   PubMed Web of Science ®Google Scholar
• Roy NS, Wei Y, Yu Y, Ying GS, Kuklinski E, Barry B, Maguire MG, Dana R, Brightwell-Arnold M, Asbell PA, for the Dry Eye Assessment and Management (DREAM) Study Group. Conjunctival HLA-DR Expression and Its Association With Symptoms and Signs in the DREAM Study. Transl Vis Sci Technol. 2019;8(4):31. doi:10.1167/tvst.8.4.31.
   PubMed Web of Science ®Google Scholar
• Enriquez-de-Salamanca A, Castellanos E, Stern ME, Fernández I, Carreño E, García-Vázquez C, Herreras JM, Calonge M. Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease. Mol Vis. 2010;16:862–873.
   PubMed Web of Science ®Google Scholar
• Ueta M, Kinoshita S. Ocular surface inflammation is regulated by innate immunity. Prog Retin Eye Res. 2012;31(6):551–575. doi:10.1016/j.preteyeres.2012.05.003.
   PubMed Web of Science ®Google Scholar
• Yamaguchi T. Inflammatory response in dry eye. Invest Ophthalmol Vis Sci. 2018;59(14):DES192–DES199. doi:10.1167/iovs.17-23651.
   PubMed Web of Science ®Google Scholar
• Sonoda S, Uchino E, Nakao K, Sakamoto T. Inflammatory cytokine of basal and reflex tears analysed by multicytokine assay. Br J Ophthalmol. 2006;90(1):120–122. doi:10.1136/bjo.2005.076737.
   PubMed Web of Science ®Google Scholar
• Rentka A, Koroskenyi K, Harsfalvi J, Szekanecz Z, Szucs G, Szodoray P, Kemeny-Beke A. Evaluation of commonly used tear sampling methods and their relevance in subsequent biochemical analysis. Ann Clin Biochem. 2017;54(5):521–529. doi:10.1177/0004563217695843.
   PubMed Web of Science ®Google Scholar
• Benito MJ, González-García MJ, Tesón M, García N, Fernández I, Calonge M, Enríquez-De-Salamanca A. Intra- and inter-day variation of cytokines and chemokines in tears of healthy subjects. Exp Eye Res. 2014;120:43–49. doi:10.1016/j.exer.2013.12.017.
   PubMed Web of Science ®Google Scholar